Genomic analysis of

Oytip Nathalang, Panasya Rassuree, Kamphon Intharanut, Wanlapa Chaibangyang, Núria Nogués

Open access · diamondAbstract read

In one paragraph

Article in African journal of laboratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 94% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Oytip NathalangGraduate Program in Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.ORCID https://orcid.org/0000-0002-2858-3063

Panasya RassureeGraduate Program in Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.ORCID https://orcid.org/0009-0000-6413-6677

Kamphon IntharanutGraduate Program in Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.ORCID https://orcid.org/0000-0002-2978-1432

Wanlapa ChaibangyangGraduate Program in Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.ORCID https://orcid.org/0000-0002-5778-6660

Núria NoguésLaboratori d'Immunohematologia Banc de Sang i Teixits, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4856-8765

Thammasat University · THBanc de Sang i Teixits · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Kell blood group system is clinically important in transfusion medicine, particularly in patients with antibodies specific to Kell antigens. To date, genetic variations of the Kell metallo-endopeptidase ( Objective: This study aimed to determine the frequencies of Methods: Blood samples obtained from 805 unrelated central Thai blood donors at a blood bank in Pathumthani, Thailand, from March 2023 to June 2023, were typed for Kp Results: All 805 (100%) donors had the Kp(a-b+) phenotype. The PCR-SSP genotyping results agreed with the column agglutination test and DNA sequencing. All 3256 Thai blood donors had the homozygous Conclusion: This study found a 100% What this study adds: This study demonstrates that in-house PCR-SSP can be used to determine

Indexed as

allelegenotypeKell blood group systemphenotypeThai population

Identifiers

PMID38629087

DOI10.4102/ajlm.v13i1.2294

PMCPMC11019069

OpenAlexW4392954556

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.